LLY
Eli Lilly and Company
LLY has the edge over MYO overall, supported by lower modeled downside and stronger fundamentals.
MYO
Myomo, Inc.
MYO's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
MYO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Unavailable |
MYO's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
MYO PE Valuation
MYO has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
MYO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect MYO's losses to shrink, with revenue growing.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over MYO on earnings quality, reporting a profit while its opponent remains loss making.
MYO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.35 | -$0.07 |
| Q2 2026 | -$0.34 | -$0.12 |
| Q1 2026 | -$0.36 | -$0.22 |
| Q4 2025 | -$0.37 | -$0.21 |
| Q3 2025 | -$0.28 | -$0.05 |
| Q2 2025 | -$0.22 | +$0.04 |
| Q1 2025 | -$0.14 | +$0.13 |
| Q4 2024 | -$0.16 | +$0.12 |
MYO is still losing money, but far less than before: $0.35 per share over the past year, against $19.35 at its worst in late 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over MYO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over MYO on profitability, with a higher operating margin.
MYO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.3M | +22% |
| Q2 2026 | $11.7M | +21% |
| Q1 2026 | $10.1M | +2.9% |
| Q4 2025 | $11.4M | -5.9% |
| Q3 2025 | $10.1M | +9.6% |
| Q2 2025 | $9.7M | +28% |
| Q1 2025 | $9.8M | +162% |
| Q4 2024 | $12.1M | +154% |
MYO's revenue is growing: $12M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -14% | +21 points |
| Q2 2026 | -19% | +28 points |
| Q1 2026 | -31% | +4.6 points |
| Q4 2025 | -24% | -22 points |
| Q3 2025 | -35% | -25 points |
| Q2 2025 | -48% | -33 points |
| Q1 2025 | -36% | +68 points |
| Q4 2024 | -2% | +49 points |
MYO's operating margin was −14% last quarter, up 21 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over MYO on cash generation, producing positive trailing cash flow while its opponent burns cash.
MYO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$1.5M |
| Q2 2026 | -$2M | +$8.1M |
| Q1 2026 | -$2.5M | +$822.4K |
| Q4 2025 | $98.1K | -96% |
| Q3 2025 | -$2.9M | -$1.1M |
| Q2 2025 | -$10.1M | -$8.1M |
| Q1 2025 | -$3.3M | -$42.2K |
| Q4 2024 | $2.5M | +$4.9M |
MYO has burned cash in almost every quarter: −$6M over the past year, against −$14M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over MYO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
MYO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2% | +873K shares |
| 1 year | +3.3% | +1.4M shares |
| 3 years | +24% | +8.3M shares |
| 5 years | +673% | +37.9M shares |
| Available history | +7768% | +43M shares |
MYO has 44M diluted shares, up 3.3% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
MYO Net Leverage
MYO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
MYO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 20.7 | Neutral |
MYO's weekly RSI is 48 (neutral) and its Stochastic is 21 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
MYO PE vs Healthcare Sector
MYO has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over MYO on trend strength, trading above more of its moving averages.
MYO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.34 | 9.7% below |
| 20 week MA | $1.32 | 8.3% below |
| 50 week MA | $1.08 | 12% above |
| 100 week MA | $2.14 | 43% below |
| 200 week MA | $2.36 | 49% below |
MYO's trend is mixed: it's above one of its five weekly moving averages, and 49% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over MYO on returns for 2026, with the stronger performance.
MYO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.08 | $6.94 | -24% |
| 2021 | $6.94 | $7.90 | +14% |
| 2022 | $7.90 | $0.44 | -94% |
| 2023 | $0.44 | $5.01 | +1039% |
| 2024 | $5.01 | $6.37 | +27% |
| 2025 | $6.37 | $1.02 | -84% |
| 2026 YTD | $1.02 | $1.21 | +19% |
MYO's yearly returns have swung widely, from +1039% in 2023 to −94% in 2022. It's up 19% so far in 2026.